DNA analysis reports

Geneyx Clinical Applications

Ready-to-use clinical application, for rapid and automated analysis and reporting  

Newmarket opportunities can be immediately addressed using our numerous ‘off-the-shelf’ ready tests and reports with a click of a button, that are fully white-labeled for your organization. Maximize your existing genetic data by providing valuable, actionable findings to your customers with previously sequenced samples. Geneyx makes it easy to identify new opportunities for genetic tests, which allows you to generate more revenues with higher margins. 

Select from our portfolio of clinical application:

Available Applications:

Carrier Screening


Pre-conception carrier screening has been a widely adopted method over the years to determine a couple’s risk of having an affected child of certain autosomal recessive and X-linked disorders. Improvements in technology and scientific knowledge have allowed for expanded carrier screening with greater detection rates of mutations for various populations. The Carrier Screening test analyzes and interprets 356 genes to give the test subjects insights about their carrier status for diseases that are severe and/or debilitating (Table 1). With this knowledge, he or she and the healthcare providers involved in their care could personalize their reproductive management plan to better prepare for and potentially prevent diseases in their future children.  

Exome sequencing (ES) can be used to analyze most of the genes in an individual at one time to identify the mutation(s) that are causing a genetic disorder or for health screening purposes. This test is most appropriate for individuals who wish to have children to determine their carrier status of disease and determine their pregnancy risk of having an affected child. ES targets the protein-coding regions of the genome, representing approximately 20,000 genes and about 2% of the genome. Individual exons of each gene are initially captured or separated from the rest of the genome and analyzed using massively parallel sequencing. The patient’s sequence is then compared to the reference genome sequence to identify variants that are different to determine their carrier status of potentially pathogenic, or likely pathogenic variants. Ideally, this test is performed by sequencing the patient and their partner together to accurately identify the inherited variants for diseases of autosomal recessive inheritance or X-linked inheritance in females and thus their pregnancy risk of having an affected child. 



Pharmacogenomics (PGx) is the study of how a person’s genes affect how he or she responds to medications. It is a powerful emerging field that promises to improve health care outcomes. PGx testing, based on SNP-Array, whole-exome or whole-genome sequencing (WES/WGS), is facilitated by Geneyx Analysis with a ready-to-use product. we provide an automatic calculation of the star alleles in all known PGx genes, and the corresponding clinical recommendation, links to relevant information, and more.  Using our PGx report, the healthcare provider can better determine what medication to prescribe that is most effective and will cause no or little adverse effects.

Gene Panels


 Geneyx Analysis provides a comprehensive portfolio of ready-to-use gene panels analysis and reports. Our gene panels contain a set of genes that have known or suspected associations with the disease or phenotype. The gene lists can be easily modified by the user.   

Our comprehensive portfolio of gene panels:


  • Bone, Skin, and Connective tissue
  • Cancer
  • Cardiology
  • Epilepsy
  • Hematology
  • Immunology
  • Inborn error of metabolism
  • Liver, Kidney, Endo, Gastro
  • Neurology
  • Monogenic diabetes
  • Ophthalmology and Hearing loss
  • Pulmonology
  • Thrombophilia
  • Parkinson
  • Customize your own